117 related articles for article (PubMed ID: 10953290)
1. Immunohistochemical study of cyclooxygenases in prostatic adenocarcinoma; relationship to apoptosis and Bcl-2 protein expression.
Tanji N; Kikugawa T; Yokoyama M
Anticancer Res; 2000; 20(4):2313-9. PubMed ID: 10953290
[TBL] [Abstract][Full Text] [Related]
2. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells.
Liu XH; Yao S; Kirschenbaum A; Levine AC
Cancer Res; 1998 Oct; 58(19):4245-9. PubMed ID: 9766645
[TBL] [Abstract][Full Text] [Related]
3. Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium.
Wang W; Bergh A; Damber JE
Prostate; 2004 Sep; 61(1):60-72. PubMed ID: 15287094
[TBL] [Abstract][Full Text] [Related]
4. Expression of cyclooxygenase-2, Bcl-2 and Ki-67 in pleomorphic adenoma with special reference to tumor proliferation and apoptosis.
Aoki T; Tsukinoki K; Karakida K; Ota Y; Otsuru M; Kaneko A
Oral Oncol; 2004 Oct; 40(9):954-9. PubMed ID: 15380175
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia.
Lee LM; Pan CC; Cheng CJ; Chi CW; Liu TY
Anticancer Res; 2001; 21(2B):1291-4. PubMed ID: 11396201
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells.
Subbarayan V; Sabichi AL; Llansa N; Lippman SM; Menter DG
Cancer Res; 2001 Mar; 61(6):2720-6. PubMed ID: 11289153
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclooxygenase-2 in prostate carcinoma.
Yoshimura R; Sano H; Masuda C; Kawamura M; Tsubouchi Y; Chargui J; Yoshimura N; Hla T; Wada S
Cancer; 2000 Aug; 89(3):589-96. PubMed ID: 10931458
[TBL] [Abstract][Full Text] [Related]
8. [Expression and significance of cyclooxygenase-2 in human pancreatic carcinomas].
Wang HX; Chen QK
Ai Zheng; 2003 Jun; 22(6):649-52. PubMed ID: 12948419
[TBL] [Abstract][Full Text] [Related]
9. Age-associated changes in the expression pattern of cyclooxygenase-2 and related apoptotic markers in the cancer susceptible region of rat prostate.
Badawi AF; Liu Y; Eldeen MB; Morrow W; Razak ZR; Maradeo M; Badr MZ
Carcinogenesis; 2004 Sep; 25(9):1681-8. PubMed ID: 15117812
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
[TBL] [Abstract][Full Text] [Related]
11. High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion.
Ryu HS; Chang KH; Yang HW; Kim MS; Kwon HC; Oh KS
Gynecol Oncol; 2000 Mar; 76(3):320-5. PubMed ID: 10684704
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma.
Lim HY; Joo HJ; Choi JH; Yi JW; Yang MS; Cho DY; Kim HS; Nam DK; Lee KB; Kim HC
Clin Cancer Res; 2000 Feb; 6(2):519-25. PubMed ID: 10690533
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 promotes prostate cancer progression.
Fujita H; Koshida K; Keller ET; Takahashi Y; Yoshimito T; Namiki M; Mizokami A
Prostate; 2002 Nov; 53(3):232-40. PubMed ID: 12386924
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of cyclooxygenase-2 protein and its relationship to apoptosis in cervical carcinoma treated with neoadjuvant chemotherapy.
Nagai N; Tian X; Mukai K; Hirata E; Kusuda T; Shiroyama Y; Shigemasa K; Ohama K
Int J Mol Med; 2003 Nov; 12(5):709-14. PubMed ID: 14532998
[TBL] [Abstract][Full Text] [Related]
15. Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal-type gastric adenocarcinoma.
Saukkonen K; Nieminen O; van Rees B; Vilkki S; Härkönen M; Juhola M; Mecklin JP; Sipponen P; Ristimäki A
Clin Cancer Res; 2001 Jul; 7(7):1923-31. PubMed ID: 11448905
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis in prostatic adenocarcinomas; a study of relationship to Ki-67 and Bcl-2 protein expression.
Tanji N; Yokoyama M; Sugamoto T; Takeuchi M; Terada N
Anticancer Res; 1998; 18(2A):1111-6. PubMed ID: 9615774
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of cyclooxygenase isoenzymes and downstream enzymes in human lung tumors.
Ermert L; Dierkes C; Ermert M
Clin Cancer Res; 2003 May; 9(5):1604-10. PubMed ID: 12738712
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ
Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772
[TBL] [Abstract][Full Text] [Related]
19. Resistance of prostate cancer cell lines to COX-2 inhibitor treatment.
Wagner M; Loos J; Weksler N; Gantner M; Corless CL; Barry JM; Beer TM; Garzotto M
Biochem Biophys Res Commun; 2005 Jul; 332(3):800-7. PubMed ID: 15907789
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma.
Zha S; Gage WR; Sauvageot J; Saria EA; Putzi MJ; Ewing CM; Faith DA; Nelson WG; De Marzo AM; Isaacs WB
Cancer Res; 2001 Dec; 61(24):8617-23. PubMed ID: 11751373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]